{"id":8587,"date":"2026-01-13T09:16:18","date_gmt":"2026-01-13T14:16:18","guid":{"rendered":"https:\/\/www.curingheartdisease.com\/?p=8587"},"modified":"2026-07-16T10:59:06","modified_gmt":"2026-07-16T14:59:06","slug":"el-futuro-del-manejo-de-las-enfermedades-cardiacas","status":"publish","type":"post","link":"https:\/\/www.curingheartdisease.com\/es\/the-future-of-heart-disease-management\/","title":{"rendered":"El futuro del tratamiento de las enfermedades card\u00edacas"},"content":{"rendered":"

El renacimiento tecnol\u00f3gico en la cardiolog\u00eda preventiva: inteligencia artificial, tomograf\u00eda coronaria cuantitativa<\/h2>\n

Introducci\u00f3n<\/h3>\n

La medicina cardiovascular est\u00e1 experimentando un cambio de paradigma sustancial, pasando de un modelo predominantemente reactivo y basado en los s\u00edntomas hacia un marco preventivo fundamentado en la detecci\u00f3n temprana y la evaluaci\u00f3n individualizada del riesgo. En el centro de esta transici\u00f3n se encuentra la integraci\u00f3n de la inteligencia artificial (IA) con la angiograf\u00eda por tomograf\u00eda computarizada coronaria (ATCC), particularmente a trav\u00e9s del desarrollo de la imagen de aterosclerosis mediante tomograf\u00eda computarizada cuantitativa (IA-QCT). Este enfoque aborda una limitaci\u00f3n de larga data en cardiolog\u00eda: la incapacidad de las herramientas diagn\u00f3sticas tradicionales para detectar de manera confiable la placa coronaria no obstructiva y rica en l\u00edpidos, a pesar de que dichas lesiones son responsables de la mayor\u00eda de los s\u00edndromes coronarios agudos y eventos de muerte s\u00fabita card\u00edaca (1).<\/p>\n

La relevancia cl\u00ednica de esta limitaci\u00f3n es sustancial. Los estudios epidemiol\u00f3gicos y patol\u00f3gicos demuestran de manera consistente que la mayor\u00eda de los infartos de miocardio provienen de placas que no limitaban el flujo antes de la ruptura (2). Dado que la enfermedad cardiovascular sigue siendo la principal causa de mortalidad en todo el mundo, y se proyecta que las muertes anuales superar\u00e1n los 20 millones para 2030, cada vez son m\u00e1s necesarios m\u00e9todos mejorados para identificar la aterosclerosis coronaria de alto riesgo antes de que ocurran los eventos cl\u00ednicos (3).<\/p>\n

\"\"<\/h3>\n

 <\/p>\n

\"\"<\/h3>\n

\"\"\"\"<\/h3>\n

Evoluci\u00f3n de la estratificaci\u00f3n del riesgo card\u00edaco y la biolog\u00eda de la aterosclerosis<\/h3>\n

La estratificaci\u00f3n tradicional del riesgo cardiovascular se basa en marcadores indirectos como los niveles de l\u00edpidos s\u00e9ricos, la presi\u00f3n arterial, el control gluc\u00e9mico, el tabaquismo y variables demogr\u00e1ficas incorporadas en calculadores de riesgo basados en poblaciones. Si bien estos modelos han demostrado ser \u00fatiles a nivel poblacional, a menudo carecen de precisi\u00f3n cuando se aplican a pacientes individuales, en particular a aquellos con perfiles de factores de riesgo aparentemente \u201cnormales\u201d que, sin embargo, albergan una enfermedad subcl\u00ednica significativa (4).<\/p>\n

La aterosclerosis es una enfermedad inflamatoria cr\u00f3nica de la pared arterial, m\u00e1s que un trastorno definido \u00fanicamente por la obstrucci\u00f3n luminal. La placa se desarrolla dentro de la \u00edntima y est\u00e1 compuesta por proporciones variables de l\u00edpidos, tejido fibroso, c\u00e9lulas inflamatorias y calcio. Las pruebas de diagn\u00f3stico convencionales \u2014incluidas las pruebas de esfuerzo, la electrocardiograf\u00eda y la angiograf\u00eda coronaria invasiva\u2014 detectan la enfermedad principalmente una vez que esta produce una estenosis hemodin\u00e1micamente significativa, definida t\u00edpicamente como un estrechamiento de la luz de 70% o m\u00e1s (5).<\/p>\n

Perspicacia 1:<\/strong> Los estudios de autopsia y angiogr\u00e1ficos demuestran que aproximadamente entre el 70 y el 75% de los infartos de miocardio se producen en vasos con una estenosis inferior al 50% antes del evento \u00edndice, lo que indica que la mayor\u00eda de los pacientes que sufren s\u00edndromes coronarios agudos no habr\u00edan sido identificados como de alto riesgo \u00fanicamente mediante pruebas de esfuerzo est\u00e1ndar (2).<\/p>\n

Perspicacia 2:<\/strong> La puntuaci\u00f3n de calcio en las arterias coronarias (CACS, por sus siglas en ingl\u00e9s) se desarroll\u00f3 para mejorar la detecci\u00f3n de la enfermedad subcl\u00ednica mediante la identificaci\u00f3n de placa calcificada. Sin embargo, la CACS no detecta placa no calcificada, y una puntuaci\u00f3n de calcio de cero no excluye la presencia de lesiones ricas en l\u00edpidos propensas a la ruptura (6).<\/p>\n

Perspicacia 3:<\/strong> AI-QCT permite la cuantificaci\u00f3n no invasiva de la carga total de placa coronaria, incluida la placa no calcificada de baja densidad, que ha demostrado tener una mayor asociaci\u00f3n con futuros eventos cardiovasculares que la gravedad de la estenosis por s\u00ed sola (7).<\/p>\n\n\n\n\n\n\n\n\n
Caracter\u00edstica de la placa<\/strong><\/td>\nVisibilidad (CACS)<\/strong><\/td>\nVisibilidad (CCTA est\u00e1ndar)<\/strong><\/td>\nVisibilidad (AI-QCT)<\/strong><\/td>\nPerfil de riesgo cl\u00ednico<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Placa calcificada<\/td>\nAlto<\/td>\nAlto<\/td>\nAlto<\/td>\nPor lo general, estable; marcador de enfermedad cr\u00f3nica<\/td>\n<\/tr>\n
Placa no calcificada<\/td>\nNinguno<\/td>\nCualitativo \/ limitado<\/td>\nCuantitativo \/ alto<\/td>\nMayor riesgo de ruptura<\/td>\n<\/tr>\n
Placa de baja densidad<\/td>\nNinguno<\/td>\nVariable<\/td>\nAlto<\/td>\nFuerte asociaci\u00f3n con ACS<\/td>\n<\/tr>\n
Volumen total de placa<\/td>\nNinguno<\/td>\nEstimaci\u00f3n indirecta<\/td>\nPreciso (mm\u00b3)<\/td>\nS\u00f3lido predictor de acontecimientos futuros<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Arquitectura t\u00e9cnica del an\u00e1lisis coronario habilitado por IA<\/h3>\n

Las plataformas de QCT basada en IA realizan un an\u00e1lisis a nivel de v\u00f3xeles del \u00e1rbol coronario en lugar de depender \u00fanicamente de la interpretaci\u00f3n visual. Estos sistemas emplean arquitecturas de aprendizaje profundo \u2014que incluyen redes neuronales convolucionales (CNN), modelos de segmentaci\u00f3n U-Net tridimensionales y clasificadores derivados de VGG\u2014 entrenadas con conjuntos de datos grandes y seleccionados que vinculan las caracter\u00edsticas de las im\u00e1genes con la validaci\u00f3n invasiva y los resultados cl\u00ednicos a largo plazo (8).<\/p>\n

Perspicacia 4:<\/strong> La IA-QCT comienza con la adquisici\u00f3n de una CCTA de alta resoluci\u00f3n. Los sistemas de TC multidetector contempor\u00e1neos, incluidos los esc\u00e1neres de 64 y 640 cortes, proporcionan la resoluci\u00f3n temporal y espacial necesaria para minimizar los artefactos de movimiento y permitir una segmentaci\u00f3n precisa de la anatom\u00eda coronaria (5).<\/p>\n

Perspicacia 5:<\/strong> Los algoritmos automatizados identifican la luz coronaria y la pared del vaso y clasifican los componentes de la placa seg\u00fan los valores de atenuaci\u00f3n en unidades Hounsfield, lo que permite diferenciar el tejido rico en l\u00edpidos, fibroso y calcificado (9).<\/p>\n

Perspicacia 6:<\/strong> Los \u00edndices de isquemia derivados de la inteligencia artificial integran la morfolog\u00eda de la placa, la longitud de la lesi\u00f3n, la remodelaci\u00f3n vascular y la geometr\u00eda luminal para estimar la limitaci\u00f3n del flujo, lo que proporciona un correlato no invasivo de la reserva fraccional de flujo (FFR) invasiva (10).<\/p>\n

Validaci\u00f3n cl\u00ednica y evidencia respaldada por pares<\/h3>\n

AI-QCT ha sido evaluada en m\u00faltiples ensayos prospectivos, registros y estudios comparativos publicados en destacadas revistas cardiovasculares y de im\u00e1genes, incluidas Journal of the American College of Cardiology<\/em>, Circulation: Cardiovascular Imaging<\/em>, y European Heart Journal \u2013 Cardiovascular Imaging<\/em> (11).<\/p>\n

Estudios emblem\u00e1ticos y registros<\/h3>\n

Revelaci\u00f3n 7:<\/strong> El ensayo CREDENCE demostr\u00f3 una gran concordancia entre el an\u00e1lisis de la ACC por inteligencia a menudo y la angiograf\u00eda coronaria cuantitativa invasiva y la FFR, lo que respalda la precisi\u00f3n diagn\u00f3stica de la IC-QCT para identificar enfermedad hemodin\u00e1micamente significativa (12).<\/p>\n

Perspicacia 8:<\/strong> El registro CONFIRM2, que abarca a decenas de miles de pacientes en m\u00faltiples pa\u00edses, demostr\u00f3 que las caracter\u00edsticas de la placa cuantificadas por IA identifican un amplio gradiente de riesgo cardiovascular entre los pacientes con enfermedad de las arterias coronarias no obstructiva (7).<\/p>\n

Perspicacia 9:<\/strong> El estudio CERTAIN demostr\u00f3 que AI-QCT mejor\u00f3 significativamente la certeza diagn\u00f3stica en comparaci\u00f3n con la interpretaci\u00f3n est\u00e1ndar, lo que dio como resultado un tratamiento m\u00e9dico m\u00e1s adecuado y menos pruebas posteriores innecesarias (1).<\/p>\n\n\n\n\n\n\n\n\n
Estudio<\/strong><\/td>\nN<\/strong><\/td>\nHallazgo clave<\/strong><\/td>\nValor p<\/strong><\/td>\nImplicancia cl\u00ednica<\/strong><\/td>\n<\/tr>\n<\/thead>\n
CONFIRMAR2<\/td>\n6,550<\/td>\nEl AUC para MACE mejor\u00f3 de 0.62 a 0.75<\/td>\n<0,001<\/td>\nMayor precisi\u00f3n pron\u00f3stica<\/td>\n<\/tr>\n
CREDENCIAS<\/td>\n513<\/td>\nAlta concordancia con la FFR invasiva<\/td>\n<0.01<\/td>\nEvaluaci\u00f3n de isquemia no invasiva viable<\/td>\n<\/tr>\n
PACIFIC-1<\/td>\n208<\/td>\nLa IA super\u00f3 a los lectores expertos<\/td>\n<0.05<\/td>\nVariabilidad interobservador reducida<\/td>\n<\/tr>\n
PROMISE (subconjunto)<\/td>\n4,347<\/td>\nReclasificaci\u00f3n de las estenosis 41%<\/td>\n\u2014<\/td>\nFalsos positivos reducidos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Implementaci\u00f3n de cardiolog\u00eda preventiva y seguimiento longitudinal de enfermedades<\/h3>\n

La integraci\u00f3n de la IA-QCT en los flujos de trabajo de cardiolog\u00eda preventiva desplaza el enfoque cl\u00ednico de la evaluaci\u00f3n epis\u00f3dica hacia el monitoreo longitudinal de la enfermedad ateroescler\u00f3tica.<\/p>\n

Perspicacia 10:<\/strong> La cuantificaci\u00f3n de la carga total de placa permite una evaluaci\u00f3n objetiva de la progresi\u00f3n o regresi\u00f3n de la enfermedad a lo largo del tiempo, lo que facilita un enfoque de tratar hasta alcanzar la meta guiado por im\u00e1genes seriadas (7).<\/p>\n

Perspicacia 11:<\/strong> Las herramientas de comparaci\u00f3n basadas en IA permiten evaluar los cambios en la composici\u00f3n de la placa, incluida la estabilizaci\u00f3n o regresi\u00f3n de la placa rica en l\u00edpidos en respuesta al tratamiento m\u00e9dico (13).<\/p>\n

Avances en hardware: Tomograf\u00eda computarizada de conteo de fotones<\/strong><\/p>\n

El rendimiento de la IA-QCT depende de la calidad de los datos de imagen de entrada, la cual contin\u00faa mejorando con los avances en el hardware de TC.<\/p>\n

Perspicacia 12:<\/strong> Los sistemas de tomograf\u00eda computarizada de conteo de fotones (PCCT) convierten directamente los fotones de rayos X en se\u00f1ales el\u00e9ctricas, lo que reduce el ruido electr\u00f3nico y los artefactos de floraci\u00f3n de calcio en comparaci\u00f3n con los detectores convencionales de integraci\u00f3n de energ\u00eda (14).<\/p>\n

Perspicacia 13:<\/strong> El TCMC ofrece una mayor resoluci\u00f3n espacial con menor radiaci\u00f3n y dosis de contraste, lo que ampl\u00eda la elegibilidad para la tomograf\u00eda computarizada coronaria a pacientes con frecuencias card\u00edacas altas, \u00edndice de masa corporal elevado o calcificaci\u00f3n coronaria extensa (15).<\/p>\n

Implicaciones econ\u00f3micas y para el sistema de salud<\/strong><\/p>\n

La adopci\u00f3n de im\u00e1genes card\u00edacas habilitadas por IA se alinea con las tendencias m\u00e1s amplias de la atenci\u00f3n m\u00e9dica hacia la atenci\u00f3n basada en el valor y la prevenci\u00f3n.<\/p>\n

Perspicacia 14:<\/strong> Los an\u00e1lisis de mercado proyectan un r\u00e1pido crecimiento de las aplicaciones de IA en cardiolog\u00eda, impulsado por una mayor eficiencia diagn\u00f3stica y posibles reducciones en los costos posteriores asociados con eventos coronarios agudos (16).<\/p>\n

Perspicacia 15:<\/strong> La identificaci\u00f3n temprana de fenotipos de placa de alto riesgo puede reducir las tasas de infarto de miocardio y los gastos m\u00e9dicos asociados al permitir una intervenci\u00f3n m\u00e1s temprana y dirigida (17).<\/p>\n

Conclusiones y direcciones futuras<\/h3>\n

La cardiolog\u00eda preventiva est\u00e1 transitando cada vez m\u00e1s hacia un modelo con base biol\u00f3gica que enfatiza la carga y composici\u00f3n de la placa en lugar de la gravedad de la estenosis por s\u00ed sola. La ACI-QCT proporciona un marco cuantitativo y reproducible para evaluar la aterosclerosis coronaria antes de que ocurran eventos cl\u00ednicos.<\/p>\n

Perspicacia 16:<\/strong> Es probable que los futuros desarrollos incluyan la integraci\u00f3n de sistemas de IA ag\u00e9ntica, modelos card\u00edacos digitales longitudinales y flujos de datos multimodales que incorporen informaci\u00f3n gen\u00f3mica y metab\u00f3lica (18).<\/p>\n

Perspicacia 17:<\/strong> A medida que la IA asume un papel m\u00e1s importante en la interpretaci\u00f3n y cuantificaci\u00f3n de im\u00e1genes, los m\u00e9dicos podr\u00edan centrarse cada vez m\u00e1s en la toma de decisiones cl\u00ednicas de alto nivel, la comunicaci\u00f3n de riesgos y la optimizaci\u00f3n de la terapia individualizada (19).<\/p>\n

Referencias<\/h3>\n
    \n
  1. Nurmohamed NS, Cole JH, Budoff MJ, et al. Impact of atherosclerosis imaging-quantitative computed tomography on diagnostic certainty, downstream testing, coronary revascularization, and medical therapy: the CERTAIN study.\u00a0Eur Heart J Cardiovasc Imaging<\/i>. 2024;25(6):857-866. doi:10.1093\/ehjci\/jeae029<\/li>\n
  2. Falk E, Shah PK, Fuster V. Rotura de placa coronaria.\u00a0Circulaci\u00f3n<\/i>. 1995;92(3):657-671. doi:10.1161\/01.cir.92.3.657<\/li>\n
  3. Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023.\u00a0J Am Coll Cardiol<\/i>. 2025;86(22):2167-2243. doi:10.1016\/j.jacc.2025.08.015<\/li>\n
  4. Lloyd-Jones DM. Predicci\u00f3n del riesgo cardiovascular: conceptos b\u00e1sicos, estado actual y direcciones futuras.\u00a0Circulaci\u00f3n<\/i>. 2010;121(15):1768-1777. doi:10.1161\/CIRCULATIONAHA.109.849166<\/li>\n
  5. Douglas PS, Hoffmann U, Patel MR, et al. Resultados de las pruebas anat\u00f3micas frente a las funcionales para la enfermedad de las arterias coronarias.\u00a0N Engl J Med<\/i>. 2015;372(14):1291-1300. doi:10.1056\/NEJMoa1415516<\/li>\n
  6. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Puntuaci\u00f3n de calcio coronario y riesgo cardiovascular.\u00a0J Am Coll Cardiol<\/i>. 2018;72(4):434-447. doi:10.1016\/j.jacc.2018.05.027<\/li>\n
  7. Feuchtner GM, Lacaita PG, Bax JJ, et al. Las caracter\u00edsticas cuantitativas de la placa coronaria por TC basadas en IA se asocian con un mayor riesgo relativo en mujeres: Registro CONFIRM2.\u00a0Circ Cardiovasc Imaging<\/i>. 2025;18(6):e018235. doi:10.1161\/CIRCIMAGING.125.018235<\/li>\n
  8. Oikonomou EK, Khera R. Machine learning in precision diabetes care and cardiovascular risk prediction.\u00a0Cardiovasc Diabetol<\/i>. 2023;22(1):259. Publicado el 25 de septiembre de 2023. doi:10.1186\/s12933-023-01985-3<\/li>\n
  9. Koo BK, Yang S, Jung JW, et al. Artificial Intelligence-Enabled Quantitative Coronary Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome.\u00a0JACC Cardiovasc Imaging<\/i>. 2024;17(9):1062-1076. doi:10.1016\/j.jcmg.2024.03.015<\/li>\n
  10. N\u00f8rgaard BL, Leipsic J, Gaur S, et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps).\u00a0J Am Coll Cardiol<\/i>. 2014;63(12):1145-1155. doi:10.1016\/j.jacc.2013.11.043<\/li>\n
  11. Beerkens FJ, Tang GHL, Kini AS, et al. Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art Review.\u00a0J Am Coll Cardiol<\/i>. 2025;85(9):944-964. doi:10.1016\/j.jacc.2024.11.051<\/li>\n
  12. Griffin WF, Choi AD, Riess JS, et al. AI Evaluation of Stenosis on Coronary CTA, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve: A CREDENCE Trial Substudy.\u00a0JACC Cardiovasc Imaging<\/i>. 2023;16(2):193-205. doi:10.1016\/j.jcmg.2021.10.020<\/li>\n
  13. Zaman S, Wasfy JH, Kapil V, et al. The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.\u00a0Lancet<\/i>. 2025;405(10486):1264-1312. doi:10.1016\/S0140-6736(25)00055-8<\/li>\n
  14. Willemink MJ, Persson M, Pourmorteza A, Pelc NJ, Fleischmann D. Photon-counting CT: Technical Principles and Clinical Prospects.\u00a0Radiology<\/i>. 2018;289(2):293-312. doi:10.1148\/radiol.2018172656<\/li>\n
  15. Schiebler ML, Jinzaki M, Yanagawa M, et al. Future Applications of Cardiothoracic CT.\u00a0Radiology<\/i>. 2025;315(3):e240085. doi:10.1148\/radiol.240085<\/li>\n
  16. Windecker S, Gilard M, Achenbach S, et al. Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.\u00a0Eur Heart J<\/i>. 2024;45(13):1104-1115. doi:10.1093\/eurheartj\/ehae069<\/li>\n
  17. Undas A, Musia\u0142 J, Z\u0105bczyk M. Antiphospholipid antibodies and atherosclerotic vascular disease: recent advances.\u00a0Rheumatol Int<\/i>. 2025;45(12):279. Published 2025 Nov 29. doi:10.1007\/s00296-025-06050-8<\/li>\n
  18. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence.\u00a0Nat Med<\/i>. 2019;25(1):44-56. doi:10.1038\/s41591-018-0300-7<\/li>\n
  19. Shetty NS, Gaonkar M, Pampana A, et al. Association of Pathogenic\/Likely Pathogenic Inherited Cardiomyopathy Variants With Heart Failure: A TOPMed Multiancestry Analysis.\u00a0Mayo Clin Proc<\/i>. 2025;100(11):1948-1955. doi:10.1016\/j.mayocp.2025.01.021<\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"

    Imagina que est\u00e1s mirando una hermosa casa. El c\u00e9sped es de un verde perfecto. Las ventanas est\u00e1n limpias y brillantes. Desde la calle, la casa parece completamente nueva. Pero detr\u00e1s de las paredes, hay un \u201cfantasma en la m\u00e1quina\u201d. Las tuber\u00edas de agua son viejas y oxidadas. Los cables el\u00e9ctricos se est\u00e1n deshilachando y echando chispas. No puedes ver estos problemas con solo mirar el exterior. Un d\u00eda, una tuber\u00eda revienta o se desata un incendio. Todos se quedan impactados. Dicen: \u201c\u00a1Pero la casa se ve\u00eda tan bien!\u201d.\u201d<\/p>","protected":false},"author":16,"featured_media":8592,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[219,220,233,225],"tags":[],"class_list":["post-8587","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lipids-medications-and-testing","category-medications-and-treatments","category-risk-screening","category-risk-genetics-special-populations"],"acf":[],"yoast_head":"\nThe Future of Heart Disease Management - The Premiere Heart Health Education Platform<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curingheartdisease.com\/es\/el-futuro-del-manejo-de-las-enfermedades-cardiacas\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Future of Heart Disease Management - The Premiere Heart Health Education Platform\" \/>\n<meta property=\"og:description\" content=\"Imagine you are looking at a beautiful house. The lawn is a perfect green. The windows are clean and shiny. From the street, the house looks brand new. But behind the walls, there is a "ghost in the machine." The water pipes are old and rusty. The electric wires are fraying and sparking. You cannot see these problems just by looking at the outside. One day, a pipe bursts or a fire starts. Everyone is shocked. They say, "But the house looked so good!"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curingheartdisease.com\/es\/el-futuro-del-manejo-de-las-enfermedades-cardiacas\/\" \/>\n<meta property=\"og:site_name\" content=\"The Premiere Heart Health Education Platform\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/curingheartdisease\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-13T14:16:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-16T14:59:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Peter Megdal PhD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RMHDInc\" \/>\n<meta name=\"twitter:site\" content=\"@RMHDInc\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Peter Megdal PhD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\"},\"author\":{\"name\":\"Peter Megdal PhD\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\"},\"headline\":\"The Future of Heart Disease Management\",\"datePublished\":\"2026-01-13T14:16:18+00:00\",\"dateModified\":\"2026-07-16T14:59:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\"},\"wordCount\":1629,\"publisher\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/post-image-21.jpg\",\"articleSection\":[\"Lipids, Medications and Testing\",\"Medications and Treatments\",\"Risk Screening\",\"Risk, Genetics and Special Populations\"],\"inLanguage\":\"es-AR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\",\"name\":\"The Future of Heart Disease Management - The Premiere Heart Health Education Platform\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/post-image-21.jpg\",\"datePublished\":\"2026-01-13T14:16:18+00:00\",\"dateModified\":\"2026-07-16T14:59:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#breadcrumb\"},\"inLanguage\":\"es-AR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-AR\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/post-image-21.jpg\",\"contentUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/post-image-21.jpg\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Future of Heart Disease Management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#website\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\",\"name\":\"The Premiere Heart Health Education Platform\",\"description\":\"To make available to the public the state of the art information on how to reverse heart disease. This is an evidence-based organization utilizing the best available science, including diet, exercise drugs, and other resources to best fight this disease.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.curingheartdisease.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-AR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\",\"name\":\"Curing Heart Disease, LLC\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-AR\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Curing-Heart-icon-red.png\",\"contentUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Curing-Heart-icon-red.png\",\"width\":512,\"height\":512,\"caption\":\"Curing Heart Disease, LLC\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/curingheartdisease\",\"https:\\\/\\\/x.com\\\/RMHDInc\",\"https:\\\/\\\/www.instagram.com\\\/rmhdinc\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCm8dh9c_D5RfJL7Z1f-yY4w\"],\"description\":\"Curing Heart Disease, LLC is an independent cardiovascular health education organization that publishes evidence-based articles, videos, podcasts, and educational tools about cardiovascular disease prevention, lipid science, nutrition, exercise, and related health topics.\",\"founder\":{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\"},\"foundingPerson\":{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\"},\"knowsAbout\":[\"Cardiovascular health\",\"Cardiovascular disease prevention\",\"Heart disease education\",\"Nutrition\",\"Exercise\",\"Lipid science\",\"Atherosclerosis\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/peters-story\\\/\",\"givenName\":\"Peter\",\"familyName\":\"Megdal\",\"honorificSuffix\":\"PhD\",\"jobTitle\":\"Nutrition Researcher and Cardiovascular Health Educator\",\"description\":\"Peter Megdal, PhD, is a nutrition researcher, cardiovascular health educator, published researcher, and longtime competitive cyclist. He earned a PhD in nutrition from the University of Massachusetts and publishes evidence-based cardiovascular health education through Curing Heart Disease.\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/peters-story\\\/\"},\"worksFor\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"affiliation\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"alumniOf\":{\"@type\":\"CollegeOrUniversity\",\"name\":\"University of Massachusetts\"},\"knowsAbout\":[\"Nutrition\",\"Cardiovascular health education\",\"Cardiovascular disease prevention\",\"Lipid science\",\"Exercise physiology\",\"Scientific research\"],\"sameAs\":[\"https:\\\/\\\/www.curingheartdisease.com\\\/author\\\/peter-megdal\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/peter-megdal-56075a2\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El futuro del manejo de las enfermedades card\u00edacas: La principal plataforma de educaci\u00f3n sobre salud card\u00edaca","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curingheartdisease.com\/es\/el-futuro-del-manejo-de-las-enfermedades-cardiacas\/","og_locale":"es_ES","og_type":"article","og_title":"The Future of Heart Disease Management - The Premiere Heart Health Education Platform","og_description":"Imagine you are looking at a beautiful house. The lawn is a perfect green. The windows are clean and shiny. From the street, the house looks brand new. But behind the walls, there is a \"ghost in the machine.\" The water pipes are old and rusty. The electric wires are fraying and sparking. You cannot see these problems just by looking at the outside. One day, a pipe bursts or a fire starts. Everyone is shocked. They say, \"But the house looked so good!\"","og_url":"https:\/\/www.curingheartdisease.com\/es\/el-futuro-del-manejo-de-las-enfermedades-cardiacas\/","og_site_name":"The Premiere Heart Health Education Platform","article_publisher":"https:\/\/www.facebook.com\/curingheartdisease","article_published_time":"2026-01-13T14:16:18+00:00","article_modified_time":"2026-07-16T14:59:06+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","type":"image\/jpeg"}],"author":"Peter Megdal PhD","twitter_card":"summary_large_image","twitter_creator":"@RMHDInc","twitter_site":"@RMHDInc","twitter_misc":{"Escrito por":"Peter Megdal PhD","Tiempo de lectura":"9 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#article","isPartOf":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/"},"author":{"name":"Peter Megdal PhD","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53"},"headline":"The Future of Heart Disease Management","datePublished":"2026-01-13T14:16:18+00:00","dateModified":"2026-07-16T14:59:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/"},"wordCount":1629,"publisher":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#primaryimage"},"thumbnailUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","articleSection":["Lipids, Medications and Testing","Medications and Treatments","Risk Screening","Risk, Genetics and Special Populations"],"inLanguage":"es-AR"},{"@type":"WebPage","@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/","url":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/","name":"El futuro del manejo de las enfermedades card\u00edacas: La principal plataforma de educaci\u00f3n sobre salud card\u00edaca","isPartOf":{"@id":"https:\/\/www.curingheartdisease.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#primaryimage"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#primaryimage"},"thumbnailUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","datePublished":"2026-01-13T14:16:18+00:00","dateModified":"2026-07-16T14:59:06+00:00","breadcrumb":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#breadcrumb"},"inLanguage":"es-AR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/"]}]},{"@type":"ImageObject","inLanguage":"es-AR","@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#primaryimage","url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","contentUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curingheartdisease.com\/"},{"@type":"ListItem","position":2,"name":"The Future of Heart Disease Management"}]},{"@type":"WebSite","@id":"https:\/\/www.curingheartdisease.com\/#website","url":"https:\/\/www.curingheartdisease.com\/","name":"La principal plataforma de educaci\u00f3n sobre la salud card\u00edaca","description":"Poner a disposici\u00f3n del p\u00fablico la informaci\u00f3n m\u00e1s avanzada sobre c\u00f3mo revertir la enfermedad card\u00edaca. Esta es una organizaci\u00f3n basada en la evidencia que utiliza la mejor ciencia disponible, incluyendo dieta, ejercicio, medicamentos y otros recursos para combatir de la mejor manera esta enfermedad.","publisher":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curingheartdisease.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-AR"},{"@type":"Organization","@id":"https:\/\/www.curingheartdisease.com\/#organization","name":"Curing Heart Disease, LLC","url":"https:\/\/www.curingheartdisease.com\/","logo":{"@type":"ImageObject","inLanguage":"es-AR","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/06\/cropped-Curing-Heart-icon-red.png","contentUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/06\/cropped-Curing-Heart-icon-red.png","width":512,"height":512,"caption":"Curing Heart Disease, LLC"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/curingheartdisease","https:\/\/x.com\/RMHDInc","https:\/\/www.instagram.com\/rmhdinc\/","https:\/\/www.youtube.com\/channel\/UCm8dh9c_D5RfJL7Z1f-yY4w"],"description":"Curing Heart Disease, LLC es una organizaci\u00f3n independiente de educaci\u00f3n sobre salud cardiovascular que publica art\u00edculos, videos, p\u00f3dcasts y herramientas educativas basados en evidencia cient\u00edfica sobre la prevenci\u00f3n de enfermedades cardiovasculares, la ciencia de los l\u00edpidos, la nutrici\u00f3n, el ejercicio y temas de salud relacionados.","founder":{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD"},"foundingPerson":{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD"},"knowsAbout":["Cardiovascular health","Cardiovascular disease prevention","Heart disease education","Nutrition","Exercise","Lipid science","Atherosclerosis"]},{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD","url":"https:\/\/www.curingheartdisease.com\/peters-story\/","givenName":"Peter","familyName":"Megdal","honorificSuffix":"PhD","jobTitle":"Nutrition Researcher and Cardiovascular Health Educator","description":"Peter Megdal, PhD es investigador en nutrici\u00f3n, educador en salud cardiovascular, autor de publicaciones cient\u00edficas y ciclista de competencia desde hace mucho tiempo. Obtuvo un doctorado en nutrici\u00f3n de la Universidad de Massachusetts y difunde informaci\u00f3n educativa sobre salud cardiovascular basada en la evidencia a trav\u00e9s de Curing Heart Disease.","mainEntityOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/peters-story\/"},"worksFor":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"affiliation":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"alumniOf":{"@type":"CollegeOrUniversity","name":"University of Massachusetts"},"knowsAbout":["Nutrition","Cardiovascular health education","Cardiovascular disease prevention","Lipid science","Exercise physiology","Scientific research"],"sameAs":["https:\/\/www.curingheartdisease.com\/author\/peter-megdal\/","https:\/\/www.linkedin.com\/in\/peter-megdal-56075a2\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/posts\/8587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/comments?post=8587"}],"version-history":[{"count":13,"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/posts\/8587\/revisions"}],"predecessor-version":[{"id":12115,"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/posts\/8587\/revisions\/12115"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/media\/8592"}],"wp:attachment":[{"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/media?parent=8587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/categories?post=8587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/es\/wp-json\/wp\/v2\/tags?post=8587"}],"curies":[{"name":"\u00a1Bien jugado!","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}